Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 119405114 | 11940511 | 4 | F | 201601 | 20160916 | 20160122 | 20160923 | EXP | US-ALEXION PHARMACEUTICALS INC-A201600273 | ALEXION | 68.66 | YR | M | Y | 0.00000 | 20160923 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 119405114 | 11940511 | 1 | PS | SOLIRIS | ECULIZUMAB | 1 | Intravenous (not otherwise specified) | 900 MG, Q2W | Y | AE12Z4B01 | 125166 | 900 | MG | CONCENTRATE FOR SOLUTION FOR INFUSION | QOW | ||||
| 119405114 | 11940511 | 2 | C | NEUPOGEN | FILGRASTIM | 1 | Subcutaneous | 300 MG, TIW | 0 | 300 | MG | TIW | |||||||
| 119405114 | 11940511 | 3 | C | VITAMIN B12 | CYANOCOBALAMIN | 1 | Oral | 1000 ?G, QD | 0 | 1000 | UG | QD | |||||||
| 119405114 | 11940511 | 4 | C | EXJADE | DEFERASIROX | 1 | Oral | 500 MG, 4 TABLETS DAILY | 0 | 500 | MG | ||||||||
| 119405114 | 11940511 | 5 | C | ASPIRIN /00002701/ | ASPIRIN | 1 | Oral | 81 MG, QD | 0 | 81 | MG | QD | |||||||
| 119405114 | 11940511 | 6 | C | ACETAMINOPHEN W/HYDROCODONE | ACETAMINOPHENHYDROCODONE | 1 | Oral | 325 MG, Q6H AS NEEDED | 0 | 325 | MG | Q6H |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 119405114 | 11940511 | 1 | Paroxysmal nocturnal haemoglobinuria |
| 119405114 | 11940511 | 2 | Myelodysplastic syndrome |
| 119405114 | 11940511 | 3 | Anaemia |
| 119405114 | 11940511 | 4 | Haemochromatosis |
| 119405114 | 11940511 | 5 | Product used for unknown indication |
| 119405114 | 11940511 | 6 | Pain |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 119405114 | 11940511 | HO |
| 119405114 | 11940511 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 119405114 | 11940511 | Anaemia | |
| 119405114 | 11940511 | Infection | |
| 119405114 | 11940511 | Localised infection | |
| 119405114 | 11940511 | Neutropenia | |
| 119405114 | 11940511 | Pancytopenia | |
| 119405114 | 11940511 | Pyrexia | |
| 119405114 | 11940511 | Transfusion related complication |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 119405114 | 11940511 | 1 | 20151106 | 20160421 | 0 |